Moreover, the populations of tolerogenic CD207+ CD103+ DCs was increased in OM-85 pretreated RSV-infected mice, and in non-infected mice, thus suggesting a reprogramming of these DCs to promote less Th2 cell subtype activation (41). The gene discussed is CD207; the disease is ocular melanoma.